ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Ending Breast Cancer by 2020? NBCC President Fran Visco Discusses the Goal

January 25, 2013

In Brief: Patterns Of care Study Leads “Part Tie” Radiotherapists To Drop Out, Sheline Says

July 22, 1977

Obesity, Faster Weight Gain, Linked To Poor Prognosis

October 28, 2005

Mammography: Panel Member Quits Over “One-Sided” Document

February 14, 1997

VeriStrat Biomarker Test Predicts Treatment Outcomes In Phase III NSCLC Trial

May 30, 2014

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014